Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain

Annals of Neurology

Volumn 56, Issue 3, 2004, Pages 407-415

  Schmierer, Klaus ^a,b   Scaravilli, Francesco ^c   Altmann, Daniel R ^a,d   Barker, Gareth J ^a,e   Miller, David H ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HUMBOLDT UNIVERSITY   (Germany)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN;

ADOLESCENT; ADULT; ARTICLE; CADAVER; CLINICAL ARTICLE; DEMYELINATION; DIGITAL RADIOGRAPHY; FEMALE; GLIOSIS; HISTOPATHOLOGY; HUMAN; IN VIVO STUDY; MALE; MORPHOMETRICS; MULTIPLE REGRESSION; MULTIPLE SCLEROSIS; MYELINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE DIAGNOSIS; RELAXATION TIME; STEREOTAXIC SURGERY;

ADULT; AGED; BRAIN; CONFIDENCE INTERVALS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN SHEATH; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 4444310685     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20202     Document Type: Article

References (53)

1. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127.
2. Dalton CM, Brex PA, Miszkiel KA, et al. New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes. Ann Neurol 2003;53:673-676.
3. McFarland HF, Barkhof F, Antel J, et al. The role of MRI as a surrogate outcome measure in multiple sclerosis. Mult Scler 2002;8:40-51.
4. Brex PA, Ciccarelli O, O'Riordan JI, et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002;346:158-164.
5. Hawkins CP, Munro PM, Mackenzie F, et al. Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain 1990;113: 365-378.
6. Katz D, Taubenberger JK, Cannella B, et al. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993;34: 661-669.
7. Brück W, Bitsch A, Kolenda H, et al. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997;42:783-793.
8. Martino G, Adorini L, Rieckmann P, et al. Inflammation in multiple sclerosis: the good, the bad, and the complex. Lancet Neurol 2002;1:499-509.
9. Moore GRW. MRI-clinical correlations: more than inflammation alone-what can MRI contribute to improve the understanding of pathological processes in MS? J Neurol Sci 2003; 206:175-179.
10. Miller DH, Johnson G, Tofts PS, et al. Precise relaxation time measurements of normal-appearing white matter in inflammatory central nervous system disease. Magn Reson Med 1989;11: 331-336.
11. Bagnato F, Frank JA. The role of nonconventional magnetic resonance imaging techniques in demyelinating disorders. Curr Neurol Neurosci Rep 2003;3:238-245.
12. MacKay A, Whittall K, Adler J, et al. In vivo visualization of myelin water in brain by magnetic resonance. Magn Reson Med 1994;31:673-677.
13. Filippi M, Rocca MA, Comi G. The use of quantitative magnetic-resonance- based techniques to monitor the evolution of multiple sclerosis. Lancet Neurol 2003;2:337-346.
14. Arnold DL, De Stefano N, Narayanan S, et al. Proton MR spectroscopy in multiple sclerosis. Neuroimaging Clin N Am 2000;10:789-798.
15. Chard DT, Griffin CM, McLean MA, et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain 2002;125:2342-2352.
16. Tofts PS. Quantitative MRI of the brain. Measuring changes caused by disease. Chichester: Wiley, 2003.
17. Bitsch A, Schuchardt J, Bunkowski S, et al. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 2000;123:1174-1183.
18. Compston A, Coles A. Multiple sclerosis. Lancet 2002;359: 1221-1231.
19. Rodriguez M. A function of myelin is to protect axons from subsequent injury: implications for deficits in multiple sclerosis. Brain 2003;126:751-752.
20. Tofts PS, Steens SCA, van Buchem MA. MT: Magnetization transfer. In: Tofts PS, ed. Quantitative MRI of the brain. Measuring changes caused by disease. Chichester: Wiley, 2003:257-298.
21. Gowland P, Stevenson VL. T1: the longitudinal relaxation time. In: Tofts PS, ed. Quantitative MRI of the brain. Measuring changes caused by disease. 1st ed. Chichester: Wiley, 2003: 111-141.
22. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46:907-911.
23. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33: 1444-1452.
24. Parker GJ, Barker GJ, Tofts PS. Accurate multislice gradient echo T(1) measurement in the presence of non-ideal RF pulse shape and RF field nonuniformity. Magn Reson Med 2001;45: 838-845.
25. Barker GJ, Tofts PS, Gass A. An interleaved sequence for accurate and reproducible clinical measurement of magnetization transfer ratio. Magn Reson Imaging 1996;14:403-411.
26. Plummer DL. Dispimage: a display and analysis tool for medical images. Riv Neuroradiol 1992;5:489-495.
27. Schmierer K, Scaravilli F, Barker GJ, et al. Stereotactic co-registration of magnetic resonance imaging and histopathology in post-mortem multiple sclerosis brain. Neuropathol Appl Neurobiol 2003;29:596-601.
28. de Groot CJ, Bergers E, Kamphorst W, et al. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain 2001;124:1635-1645.
29. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338: 278-285.
30. van der Valk V, de Groot CJ. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol Appl Neurobiol 2000;26:2-10.
31. Prineas JW, McDonald WI, Franklin RJM. Demyelinating diseases. In: Graham DI, Lantos PC, eds. Greenfield's neuropathology. Vol 2. 7th ed. London: Arnold, 2002:471-550.
32. Mize RR, Holdefer RN, Nabors LB. Quantitative immunocytochemistry using an image analyzer. I. Hardware evaluation, image processing, and data analysis. J Neurosci Methods 1988;26:1-23.
33. Gentleman SM, McKenzie JE, Royston MC, et al. A comparison of manual and semi-automated methods in the assessment of axonal injury. Neuropathol Appl Neurobiol 1999;25:41-47.
34. Huber PJ. The behavior of maximum likelihood estimates under non-standard conditions. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability. 1st ed. Berkeley, CA: University of California Press, 1967:221-233.
35. Carpenter JR, Bithall JF. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med 2000;19:1141-1164.
36. Davies GR, Ramaio-Torrental L, Hadjiprocopis A, et al. Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2004;75:998-1002.
37. Barkhof F, Brück W, De Groot CJ, et al. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol 2003;60:1073-1081.
38. van Waesberghe JH, Kamphorst W, de Groot CJ, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46:747-754.
39. Mottershead JP, Schmierer K, Clemence M, et al. High field MRI correlates of myelin content and axonal density in multiple sclerosis-a post-mortem study of the spinal cord. J Neurol 2003;250:1293-1301.
40. Stanisz GJ, Kecojevic A, Bronskill MJ, et al. Characterizing white matter with magnetization transfer and T(2). Magn Reson Med 1999;42:1128-1136.
41. Henkelman RM, Stanisz GJ, Graham SJ. Magnetization transfer in MRI: a review. NMR Biomed 2001;14:57-64.
42. Vavasour IM, Whittall KP, Li DK, et al. Different magnetization transfer effects exhibited by the short and long T(2) components in human brain. Magn Reson Med 2000;44:860-866.
43. Stanisz GJ, Webb S, Munro CA, et al. MR properties of excised neural tissue following experimentally induced inflammation. Magn Reson Med 2004;51:473-479.
44. Gareau PJ, Rutt BK, Karlik SJ, et al. Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS. J Magn Reson Imaging 2000;11:586-595.
45. Prineas JW, Barnard RO, Kwon EE, et al. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 1993;33:137-151.
46. Tozer D, Ramani A, Barker GJ, et al. Quantitative magnetization transfer mapping of bound protons in multiple sclerosis. Magn Reson Med 2003;50:83-91.
47. Schmierer K, Scaravilli F, Davies GR, et al. The macromolecular proton fraction in post-mortem MS brain: a correlative MT-MRI/histology study. Neurology 2003;60(suppl 1):A423.
48. Charcot M. Histologie de la sclerose en plaques. Gaz Hosp 1868;141:554-558.
49. Greenfield J, King L. Observations on the histopathology of cerebral lesions in disseminated sclerosis. Brain 1936;59:445-458.
50. Ferguson B, Matyszak MK, Esiri MM, et al. Axonal damage in acute multiple sclerosis lesions. Brain 1997;120:393-399.
51. Evangelou N, Esiri MM, Smith S, et al. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000;47:391-395.
52. van Walderveen MA, Kamphorst W, Scheltens P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998;50: 1282-1288.
53. Allen IV, McQuaid S, Mirakhur M, et al. Pathological abnormalities in the normal-appearing white matter in multiple sclerosis. Neurol Sci 2001;22:141-144.